DMK
David M. Knott Portfolio holdings
AUM
$264M
This Quarter Return
+2.31%
1 Year Return
+57.14%
3 Year Return
+78.48%
5 Year Return
+218.77%
10 Year Return
–
AUM
$170M
AUM Growth
+$170M
(-7%)
Cap. Flow
-$12.9M
Cap. Flow
% of AUM
-7.57%
Top 10 Holdings %
Top 10 Hldgs %
60.5%
Holding
104
New
11
Increased
14
Reduced
10
Closed
4
Top Buys
| 1 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
$1.42M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.37M |
| 3 |
MDWT
Midwest Holding Inc. Common Stock
MDWT
|
$1.25M |
| 4 |
TG Therapeutics
TGTX
|
$1.04M |
| 5 |
FibroGen
FGEN
|
$811K |
Top Sells
| 1 |
SRCL
Stericycle Inc
SRCL
|
$6.88M |
| 2 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$3.75M |
| 3 |
KKR & Co
KKR
|
$2.75M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$2.47M |
| 5 |
Ligand Pharmaceuticals
LGND
|
$2.38M |
Sector Composition
| 1 | Healthcare | 39.75% |
| 2 | Financials | 16.69% |
| 3 | Industrials | 12.97% |
| 4 | Technology | 9.75% |
| 5 | Communication Services | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ligand Pharmaceuticals
LGND
$3.15B
| $23.6M | 13.87% | 248,041 -25,000 | -9% | -$2.38M |
|
2
Upland Software
UPLD
$81.4M
| $15.3M | 8.99% | 406,500 | – | – |
|
3
Apollo Global Management
APO
$77.9B
| $13.4M | 7.88% | 300,000 | – | – |
|
4
FTAI Aviation
FTAI
$15.8B
| $12M | 7.04% | 700,000 | – | – |
|
|
SRCL
5
DELISTED
Stericycle Inc
SRCL
| $10.1M | 5.92% | 160,000 -109,083 | -41% | -$6.88M |
|
6
Alphabet (Google) Class C
GOOG
$2.58T
| $8.23M | 4.83% | 5,600 | – | – |
|
7
FS KKR Capital
FSK
$5.11B
| $6.27M | 3.68% | 395,175 | – | – |
|
8
Calumet Specialty Products
CLMT
$1.41B
| $5.15M | 3.02% | 2,020,000 | – | – |
|
9
Pfizer
PFE
$141B
| $4.84M | 2.84% | 131,900 | – | – |
|
10
LKQ Corp
LKQ
$8.39B
| $4.16M | 2.44% | 150,000 | – | – |
|
|
11
KKR & Co
KKR
$124B
| $3.43M | 2.01% | 100,000 -80,000 | -44% | -$2.75M |
|
12
AbbVie
ABBV
$372B
| $3.31M | 1.94% | 37,769 | – | – |
|
13
Kennedy-Wilson Holdings
KW
$1.21B
| $3.05M | 1.79% | 210,000 | – | – |
|
|
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.92M | 1.71% | 37,531 +1,000 | +3% | +$77.7K |
|
15
Bristol-Myers Squibb
BMY
$96B
| $2.8M | 1.64% | 46,409 | – | – |
|
|
TRIL
16
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.5M | 1.47% | 176,215 -88,010 | -33% | -$1.25M |
|
|
KDMN
17
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.4M | 1.41% | 612,000 +174,400 | +40% | +$684K |
|
|
EIGR
18
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.24M | 1.31% | 275,348 +11,600 | +4% | +$94.4K |
|
19
JPMorgan Chase
JPM
$829B
| $2.22M | 1.3% | 23,050 | – | – |
|
|
ZGNX
20
DELISTED
Zogenix, Inc.
ZGNX
| $2.02M | 1.19% | 112,707 +7,100 | +7% | +$127K |
|
21
Aurinia Pharmaceuticals
AUPH
$1.58B
| $1.98M | 1.16% | 134,600 +19,790 | +17% | +$292K |
|
22
Xenon Pharmaceuticals
XENE
$2.98B
| $1.96M | 1.15% | 177,000 +8,000 | +5% | +$88.5K |
|
23
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $1.83M | 1.07% | 99,493 -5,073 | -5% | -$93.1K |
|
|
BDSI
24
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.8M | 1.05% | 481,930 -23,600 | -5% | -$88K |
|
25
MPLX
MPLX
$51.8B
| $1.57M | 0.92% | 100,000 | – | – |
|